Stroke 2025 | London | United Kingdom | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

"Brain Health and Stroke: A Lifespan Approach"

- Stroke 2025

Welcome Message

We are thrilled to announce that the "14th International Conference on Neurological Disorders and Stroke" will be held as a hybrid event in London, United Kingdom, from May 21–22, 2025.

The 2025 in-person conference in London promises an exceptional two-day program, where we will showcase the latest breakthroughs in neurology medicine and stroke care alongside peers and colleagues from around the globe.

This conference aims to foster the exchange of scientific knowledge and build camaraderie among experts dedicated to the challenging and dynamic field of Neurological Disorders and Stroke.

The Stroke Conference 2025 will place a strong emphasis on delivering high-quality keynote presentations, speaker sessions, seminars, and a dedicated young researchers' forum to highlight cutting-edge advancements in the field.

We are honored to invite distinguished academics, researchers, physicians, residents, and fellows from across the world to share the most innovative ideas and developments in stroke and neurological disorders.

We eagerly look forward to welcoming you to London for this prestigious Stroke Conference.

With best wishes,
Organizing Committee | Stroke 2025

About

We are excited to announce the 14th International Conference on Neurological Disorders and Stroke, which will take place in London, United Kingdom, from May 21–22, 2025. This two-day conference is specifically designed for medical experts dedicated to advancing our understanding and management of neurological disorders and stroke. Our primary goal is to provide practitioners with a comprehensive update on the latest advancements in neurology and stroke research, with a focus on innovative approaches and emerging trends.

The conference's central theme, "The Future of Neurological Care: A Global Challenge," underscores its worldwide significance and our commitment to addressing the most pressing issues in the field.

The conference will emphasize precision methods for the diagnosis, treatment, prognosis, prevention, and monitoring of neurological disorders and stroke. Attendees will gain insights into cutting-edge research and clinical practices that are shaping the future of neurology.

The event will feature a diverse program, including keynote addresses, panel discussions, instructional sessions, video presentations, and poster displays. This hybrid conference will offer both in-person participation in London and virtual attendance via the Webex platform, enabling global collaboration and knowledge sharing. The hybrid format ensures that participants can engage in meaningful discussions, exchange ideas, and build professional networks, regardless of their location.

Conference Format:
The 14th International Conference on Neurological Disorders and Stroke will be held in person in the vibrant city of London, United Kingdom, and online via the Webex platform. On-demand sessions will be available, and all recordings will be accessible for six months after the conference. Whether you attend in person or virtually, you can revisit the content at your convenience to catch up on any sessions you may have missed.

Learning Objectives:

Apply the latest treatment modalities and therapies in the field of neurological disorders and stroke.
Incorporate current evidence-based research into the management of neurological conditions.
Stay updated on practical applications influencing operative procedures, pharmaceuticals, and medical devices.
Understand the latest evidence-based clinical pathways and best practices.
Review patient outcomes based on peer-reviewed research.

Why Attend the 2025 Conference?

Professional Development: Enhance your skills and knowledge in neurology and stroke care.
Networking Opportunities: Connect with leading experts, researchers, and practitioners from around the world.
Access to Cutting-Edge Research: Learn about the latest breakthroughs and innovations in the field.
Exposure to New Products and Technologies: Explore advancements in medical devices and pharmaceuticals.
Continuing Education Credits: Earn credits to support your professional growth.
Enhance Reputation and Credibility: Gain recognition by participating in a prestigious international conference.

Target Audience:

Physicians and Surgeons
Healthcare Analysts
Students, Interns, and Residents
Research Faculties
Doctors and Nurses
Directors, Managers, and CEOs
Presidents & Vice Presidents
Scientists and Professors
Academic Scientists
Medical Colleges and Universities
Societies & Associations
Business Entrepreneurs
Training Institutes

Opportunities for Researchers:

Present your work through oral presentations, poster sessions, or symposiums.
Publish your research in conference proceedings or special issues of journals.
Engage in speaker presentations and poster displays to share your findings with a global audience.

We look forward to welcoming you to the 14th International Conference on Neurological Disorders and Stroke in London. Together, we can collaborate, innovate, and advance our understanding of these critical health challenges.

With best wishes,
Organizing Committee | Stroke 2025

Past Conference

The Stroke 2024 annual meeting is the ideal platform because, motto of Allied Group's is to give attendees the most exposure possible, we make sure the event is a mix of professionals from academia, and medicine, including Neurologists, Neuroimaging Specialists, Neurosurgeons, Neuroscientists, Experts, Scholars, and Researchers.

“Creating a Future Map for Neurological Disorders and Stroke” will be the focus of the Neurological Disorders and Stroke Conference. Our mission is to offer a fantastic curriculum that covers the whole spectrum of research and advancements in treatment and diagnosis, as well as share cross-cultural experiences with diverse treatment methods and rehabilitation strategies.

Stroke conference is an annual conference where committees, allied health professionals, and consultants from the field of neurology get together to discuss how to improve diagnosis, treatment, and stroke care in the future.

Why to attend?

Among participants from all around the world interested in learning about Neurological Disorders and Stroke, therapies, and advancements, this is your best chance to connect with the largest group of neurological community members. During this conference, you may create a splash with novel advancements in Neurological disorders and stroke, therapy, and diagnostics, network with existing and future scientists, deliver talks, share information, and get your name out there. To promote a person's overall health, which includes their physical, emotional, spiritual, and social well-being, Stroke 2023 is provided. World-famous speakers, the most recent methods, innovations, and updates in the field of Neurological disorders and stroke.

Target Audience:

Neurologists
Neuroimaging Specialists
Neuroscientists
Clinical Neuropsychologists
Cognitive Neuroscientists
Neurosurgeons
Neuropathologists
Biostatisticians
Scientific Writers
Students
Clinicians and researchers
Medical Directors
Healthcare Professionals

Conference Opportunities

For Researchers and Faculty Members:

Poster Display
Speaker Presentations
Workshop organizing

For Students and Research Scholars:

Poster
Student Attendee
Group Registrations
Young Researcher Forum
For Business Delegates:
Speaker opportunity
Networking opportunities
Delegate participation

Past Conference Report

On December 04-06, 2024, in London, UK, the 12th International Conference on Neurological Disorders and Stroke was successfully held.

The diverse crowd from around the world that graciously attended Stroke 2023 and represented the field of Neurology and Neurological Diseases contributed to its success.

The 12th International Conference on Vascular Dementia and Dementia was co-located with the event at the Sheraton Heathrow, Heathrow Airport, Colnbrook Bypass, West Drayton, UB7 0HJ, United Kingdom, over the same dates.

People from all around the world working in the different fields of neurology, neuroscience, and associated illnesses were present, and the attendees enjoyed mingling and networking with them.

The conference's speeches on the subject of "Innovations in Diagnostics, Treatments, and Rehabilitation of Neurological Diseases and Stroke" had a powerful echo.

The organizing committee for Stroke 2023 would like to extend its gratitude to Randall Higashida from the University of California, San Francisco, in the United States, as well as to the other members and on-site coordinator. The following special and keynote speeches elevated the conference:

Patricia A Quigley | Nurse Consultant LLC | USA
Koji Abe | Okayama University | Japan
Si Ching Lim | Changi General | UK
Limin Yong | NTUC Health | Singapore
David Truswell | SomeFreshThinking LTD | UK
Hischam Bassiouni | Klinikum St. Marien Amberg | Germany
Veronica Franklin Gould | Arts4Dementia | UK
Andras Folyovich | Szent Janos Hospital | Hungary
Gibran Franzoni Rufca | Hospital Santa Casa de Ourinhos | Brazil
Uriel Rael Moreno Araujo | Hospital General 450 Durango | Mexico
Ruth Akiyo Mizoguchi | Chelsea and Westminster Hospital | UK
Nourah Alruwais | The University of Sussex | UK

Stroke 2024 expresses gratitude to the members of the organising committee, particularly the chair and co-chairs of both the Stroke 2024 and Vascular Dementia 2024 conferences, Chan Hong Park, Walter Bini, Xiu Liu, Walid Attia, Malini Narayanan, Muhammad Qazafi Memon, Ali Fahir Ozer Anthony Hammond, Liz Karter, Pankaj Nishikant Surange, and Giancarlo Guizzardi.

https://stroke.alliedacademies.com/ provides further information on the previous event.

Scientific Sessions

Scientific tracks

Neurological Disorders
Neurology
Neuroscience
Stroke
Ischemic Stroke
Dementia
Epilepsy
Psychiatry
Amyloidosis
Animal Models Testing
Guillain Barre Syndrome
Parkinson’s Diseases
Alzheimer's Disease
Neuroimaging And Neurosonology
Neurodegenerative Disorders
Cerebrovascular Disease
Neonatal And Pediatric Stroke
Cognitive Impairment
Demyelinating Disease
Movement Disorders
Pediatric Neurology
Neurotherapy
Psychology

Session on Neurological Disorders

Diseases of the central and peripheral nervous systems are considered neurological disorders. These conditions include neurological problems as a result of malnutrition, epilepsy, Alzheimer's disease, and other dementias, cerebrovascular diseases such as stroke, migraine, and other headache disorders, multiple sclerosis, Parkinson's disease, neuro infections, and brain tumors.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Neurology

In 2020, the size of the worldwide neuroscience market was $36.5 billion. Looking ahead, IMARC Group projects that the market will increase at a compound annual growth rate (CAGR) of 4.1% from 2022 to 2028, reaching $46.2 billion by 2031. Neurology is a rapidly evolving field, with ongoing research and development of new treatments and therapies. Advances in neuroscience and technology have led to an improved understanding of the brain and nervous system, and opened up new avenues for the diagnosis and treatment of neurological disorders.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Neuro Science

Modern Neuroscience has several branches, such as affective neuroscience, behavioral neuroscience, cellular neuroscience, clinical neuroscience, cognitive neuroscience, cultural neuroscience, molecular neuroscience, and social neuroscience.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Stroke

In recent days, so many people have been affected by Stroke, including infants. The stroke management market is divided into hospitals, diagnostic centres, outpatient surgical centres, and others. In 2021, the hospital sector has a market share of nearly 42 percent. Too many individuals lose their lives to strokes. How to prevent stroke, types of strokes, and other disorders can be elaborated through the Stroke 2023. The types of strokes are Brain stroke, pediatric stroke, Neonatal stroke, and Ischemic stroke.

Related conference:

Related associations:

Related Journals:

Related Societies:

Session on Ischemic stroke

Ischemic stroke is also called brain stroke. Because when the blood flow to a portion of the brain is blocked or diminished, brain tissue cannot get oxygen and nutrients, which results in an ischemic stroke. In minutes, brain cells start to degenerate. In recent years so many people have been affected by Ischemic stroke due to a lack of blood supply in the brain.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Dementia

Dementia is a type of Neurological Disorder, It is a set of symptoms that substantially affect memory, thinking, and social abilities and are referred to as dementia when they significantly interfere with day-to-day functioning. Numerous conditions can cause dementia, even if there isn't one specific sickness that does.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Epilepsy

Epilepsy is one of the Neurological disorders that cause seizures or periods of unusual behavior, abnormal brain activity sensations, and sometimes loss of awareness. Both men and women in all ethnic groups are affected by epilepsy. According to data from the World Health Organization, the average cost of healthcare per person globally in 2018 was USD 1,154.731. The cost of healthcare per person globally went from USD 784.313 in 2010 to USD 1,320.841 in 2019, with the United States as the top payer at USD 11,643.85 per capita in 2019.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Psychiatry

In the field of medicine known as psychiatry, mental, emotional, and behavioral problems are identified, treated, and prevented. A psychiatrist is a medical specialist who focuses on mental health, notably substance use disorders.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Amyloidosis

The market for treatments for transthyretin amyloidosis was valued at USD 4.822 billion in 2020 and is projected to grow to USD 7.11 billion by 2025. The size of the worldwide market for amyloidosis treatments was estimated at USD 3.7 billion in 2018 and is projected to grow at a CAGR of 6.9% during the forecast period. Some of the reasons that will jointly drive the market are the expanding elderly population, the increased acceptance of innovative targeted treatments and transplantation, the introduction of biologics, and these.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Animal Models Testing

In recent years Animal models Testing was such a trending topic in Neurology. The market for animal models was valued at USD 17.27 billion in 2019 and is anticipated to rise to USD 29.08 billion by 2025, at a CAGR of 10.29%. Neuroscience, pharmacology, toxicology, and genetics are just a few of the scientific areas that employ animal models. Animals including mice, rats, rabbits, dogs, and non-human primates are frequently utilized as models those will be briefly elaborated in Stroke Conference.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Guillain-Barre Syndrome

Peripheral nervous system disease called Guillain-Barre syndrome. During the projection period, 2021-2026, the Guillain-Barre Syndrome Market Study is expected to expand at a CAGR of 4.9%. The COVID-19 virus has a substantial effect on the market for Guillain-Barre syndrome (GBS) treatments.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Parkinson’s Diseases

Tremors, stiffness, bradykinesia (slow movement), and postural instability are all signs of Parkinson's disease. Other symptoms may include a loss of smell, sleep disturbances, constipation, depression, and cognitive impairment. The market for medications for Parkinson's disease was estimated to be worth $5.9 billion globally in 2020; it is anticipated to increase to $11.2 billion by 2028, with a CAGR of 6.8% from 2020 to 2035. Parkinson's disease is a neurodegenerative condition commonly known as idiopathic Parkinsonism.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Alzheimer's Disease

Alzheimer's disease is a neurodegenerative disorder that affects the brain, causing a decline in cognitive function and memory loss. In older people, it is the most typical cause of dementia. The Global market rate for Alzheimer’s disease was estimated to be worth $4.3 billion in 2019 and $6.2 billion by 2023, with a CAGR of 6.3% during the period of 2019-2023.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Neuroimaging and Neurosonology

Neuroimaging and neurosonology are both diagnostic tools used in the field of neurology to help visualize and study the structure and function of the brain and nervous system. Neuroimaging refers to a group of techniques used to create images of the brain and its structures. Neurosonolgy is one of the diagnostic tools that use ultrasound technology.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Neurodegenerative Disorders

The market for neurodegenerative diseases was estimated to be worth USD 39,125 million in 2020, and it is anticipated to grow to USD 78,295 million by 2035, showing a CAGR of 6.2% during the projected period (2020–2035).

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Cerebrovascular Disease

Treatment for Cerebrovascular disease depends on the underlying condition and the severity of the symptoms. Medications may be used to help prevent blood clots and reduce the risk of stroke or TIA, and surgery or endovascular procedures may be necessary to repair damaged blood vessels or prevent further damage. Cerebrovascular disease knowledge was very important these are briefly elaborated on the Stroke 2023.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Neonatal and Pediatric Stroke

For neonatal and pediatric stroke, respectively, the average adjusted 5-year expenditures are significant at $54,719 and $135,168. The average price of admission for a youngster with a stroke was $91,869. Neonatal stroke birth admission expenses were on average $49,633; when these prices were adjusted for control birth admission costs, the difference was just $5,792, indicating that the stroke was responsible for 87% of the expenditures.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Cognitive Impairment

Depending on the underlying reason, treatment for cognitive impairment may involve drugs to control symptoms, cognitive and behavioral therapy, lifestyle changes, and supportive care. Early detection and treatment of cognitive impairment are crucial because certain causes of it may be reversible if discovered and addressed quickly enough. The cognitive impairment will be explained in Stroke 2023.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Demyelinating Disease

The protective coating known as the myelin sheath, which covers nerve fibers in the central and peripheral nervous systems, is a structure that is harmed by a set of illnesses known as demyelinating diseases. Numerous symptoms, including muscular weakness, tingling or numbness in the limbs, issues with balance and coordination, as well as issues with vision and speech, can be brought on by these illnesses.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Movement Disorders

This market research study on the treatment of dementia and movement disorders offers insightful information on the market's response to COVID-19, which will assist businesses in assessing their strategic business plans. The researcher at Technavio projects that the market for treating dementia and mobility disorders would be worth USD 8.14 billion by 2030, growing at a CAGR of 7.95%.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Pediatric Neurology

A specialty of medicine called pediatric neurology is dedicated to identifying and treating neurological disorders in infants and children. Pediatric neurologists are medical professionals with specialized training in this area who are prepared to treat newborns, kids, and teenagers with neurological issues.

Related conference:

Related associations:

Related Societies:

Related Journals:

Session on Neurotherapy

Neurotherapy, also known as neurofeedback or EEG biofeedback, is a type of therapy that uses real-time feedback from the brain to help individuals learn to regulate and control their brainwave activity. The market for Neurotherapy is anticipated to reach $ 1,236.6 million in 2021 and grow at a CAGR of 7.4% from 2021 to 2027.

Related conference:

Related associations:

Related Societies:

Related Journals:

Market Analysis

With a CAGR of 8.8%, the market for stroke management is projected to increase from its 2015 valuation of $33,705.30 million to $66,871.95 million by 2025. A stroke occurs when a blood vessel in the brain breaks and starts to bleed, or when the brain's blood supply is interrupted. The rupture or blockage prevents blood and oxygen from getting to the brain's tissues. Three different forms of stroke are common all around the world transient ischemic attack, ischemic stroke, and hemorrhagic stroke. Blood tests, computed tomography scans, magnetic resonance imaging, ultrasound, cerebral angiograms, and echocardiograms are used to diagnose stroke. Aspirin, various antiplatelet medications, and anticoagulants are used in the treatment of stroke.

The market for neurology devices is predicted to expand at a CAGR of about 9.11% over the course of the projection period (2015-2025). The COVID-19 pandemic had a significant impact on the world's healthcare systems, with negative effects that were felt both by people who were infected and by others. As a result, treatment and surgical procedures have to be delayed to manage and save resources.

For instance, the World Health Organization released the findings of a survey that was conducted by 145 countries over the course of three weeks in June 2020. The results revealed that the prevention and treatment services for numerous chronic diseases, including numerous neurodegenerative disorders like Parkinson's, Alzheimer's, and dementia, had been severely disrupted, and this has become a significant concern because people with chronic diseases are more likely to experience severe COVID-19. Moreover, services were completely or partially disrupted in 48% of the nations.

The market for medications for neurological disorders is expected to reach a staggering $ 156.60 billion in value between 2015 and 2025, according to forecasts for market size, share, industry growth, competitive analysis, and trends. With a CAGR of 8.9%, the market for treatments for the central nervous system is anticipated to increase from $86.02 billion in 2020 to $174.38 billion in 2030.

About 15% of people in 2015 will have neurological disorders, based on the WHO. According to scientists' estimates, 40 million individuals already suffer from neurodegenerative disorders, and by 2040, that number will rise to 125 million. According to a report by the UN, 7.8 million people worldwide die from neurological diseases each year, accounting for approximately 1 in 5 of the world's population.

Over the projected period of 2015–2030, the ischemic cerebral stroke market is anticipated to increase. The market is projected by Data Bridge Market Research to expand at a CAGR of 8.7% over the aforementioned forecast period. An ischemic cerebral stroke happens when blood clots block blood arteries that provide blood to the brain, which impairs neurologic function. An ischemic cerebral stroke is indicated by the abrupt development of hemiparesis, quadriparesis, and mono paresis as well as monocular vision loss, diplopia, visual field deficits, chemosensory deficits, dysarthria, facial droop, vertigo, ataxia, nystagmus, aphasia, and a deterioration in mental status.

The market for the Guillain barre syndrome is anticipated to grow at a 5.20% CAGR from 2022 to 2030, reaching USD 608.62 million. An uncommon immune system condition is called Guillain-Barre Syndrome. The immune system of the patient targets the neurological system in this medical disease. Unknown substances are responsible for Guillain-Barre Syndrome. Guillain-Barre Syndrome frequently manifests as limb weakness, breathing difficulties, low or high blood pressure, and problems moving the eyes or face.

The size of the world market for stroke management, which was estimated to be worth $33,702.20 million in 2015, is expected to grow to $68,791.85 million by 2030, a CAGR of 7.3% from 2016 to 2025. A stroke occurs when a blood artery in the brain breaks and starts to bleed, or when the brain's blood supply is interrupted. The rupture or blockage prevents blood and oxygen from getting to the brain's tissues.

During the projected period, the neuroscience market is anticipated to grow at a 3.9% CAGR. Several research papers have been released to provide light on how the pandemic has affected the market under investigation. For instance, according to a study titled "Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic," which was published in October 2021, an additional 72.2 million people were thought to be suffering from anxiety disorders in that year. Compared to 2020, the number of instances increased by 25.5% in 2021. In most nations, there is now a greater need to improve mental health services as a result of this epidemic.

Organizing committee members

Dr. Joel I. Osorio

CEO, Neurology

RegenerAge Clinic, Mexico

Radu Mutihac

Professor

Ecological University of Bucharest, Romania

Pat Quigley

Nurse consultant, Nurse Consultant, LLC

VISN 8 Patient Safety Center, USA

George Perry

Neuropathology

The University of Texas, USA

Dr. M. Raafat El-Gewely

Professor, Medical Biology

University of Tromsø, Norway

W S El MasrI

Managing Director

Midland Centre for Spinal Injuries, UK

Renowned Speakers

Dr. Edward Snowden

Doctor

American Autism Association, USA

Dr. Merlin Larson

Doctor

University of Salamanca, Spain

Dr. Robert Felix

Doctor

Anglia Ruskin University, UK

Prof. Annamaria Micheal

Professor

University of Foggia,, Italy

Dr. Julia Fagen

Professor

University of North Carolina School of Medicine,, USA

Dr. Richard Anderson

Professor

University of Ottawa, Canada

To Collaborate Scientific Professionals around the World

Conference Date	May 21-22, 2025
Poster Oppurtunity	Available
e-Poster Oppurtunity	Available

Testimonials

Rajendra Badgaiyan

Chairman, Richmond University Medical Center, New York, USA.

I want to thank you sincerely for the outstanding conference you put together. It was more than I could have imagined and was simply astounding.Their presentations' ability to be both educational and motivating. I learnt a lot from the numerou